Kyoto University
Also known as: Associate Professor of Medicine, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine | Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine | Graduate School of Medicine, Kyoto University | Instructor in Medicine, Department of Clinical Laboratory Medicine, Kyoto University Hospital | Kyoto University | Kyoto University, Graduate School of Medicine | Kyoto University Graduate School of Medicine / School of Public Health | Kyoto University Hospital | Professor of Medicine, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine | Professor of Medicine, Department of Clinical Laboratory Medicine, Kyoto University Hospital | Satoshi Shizuta | Takeshi Morimoto
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2003Last known activity
May 1, 2025
Timeline
1890s
- Jan 1, 1897
Kyoto University— Founded
Drugs by trial phase (66 distinct, 50 trials)
Phase 4 (26 own, 0 via acquisition)
Phase 3 (13 own, 0 via acquisition)
Phase 2 (20 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Alzheimer Disease
- Atrial Fibrillation
- Biliary Tract Neoplasms
- Breast Neoplasms
- Candidiasis
- Carcinoma
- Carcinoma, Ductal
- Carcinoma, Ductal, Breast
- Carcinoma, Hepatocellular
- Carcinoma in Situ
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Non-Small-Cell Lung
- Colitis
- Colitis, Ulcerative
- Coronary Artery Disease
- Coronary Disease
- Depression
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Edema
- Hepatic Insufficiency
- Hepatitis C
- Hepatitis C, Chronic
- Hypercholesterolemia
- Infarction
- Infections
- Liver Cirrhosis
- Liver Failure
- Liver Failure, Acute
- Liver Neoplasms
- Lung Neoplasms
- Macular Edema
- Myocardial Infarction
- Myocardial Ischemia
- Prostatic Neoplasms
- Recurrence
- Renal Insufficiency
- Small Cell Lung Carcinoma
- Stomach Neoplasms
- Thrombosis
- Ulcer
- Urinary Bladder Neoplasms
- Venous Thrombosis
Recent trials (50)
- NCT06983210CollaboratorPhase 2May 1, 2025
- NCT06723145OfficialPhase 4Jan 20, 2025
- NCT06723145Sponsor investigatorPhase 4Jan 20, 2025
- NCT06723145Lead sponsorPhase 4Jan 20, 2025
- NCT06482268CollaboratorPhase 1Jun 1, 2024
- NCT05879653Overall official - principal investigatorPhase 2Oct 1, 2023
- NCT05879653OfficialPhase 2Oct 1, 2023
- NCT05879653Sponsor investigatorPhase 2Oct 1, 2023
- NCT05879653Reponsible party - principal investigatorPhase 2Oct 1, 2023
- NCT05879653Lead sponsorPhase 2Oct 1, 2023
- NCT05347069Sponsor investigatorPhase 4Jun 14, 2022
- NCT05347069Overall official - principal investigatorPhase 4Jun 14, 2022
- NCT05347069Lead sponsorPhase 4Jun 14, 2022
- NCT04724460Lead sponsorPhase 4Feb 18, 2021
- NCT04724460Sponsor investigatorPhase 4Feb 18, 2021
Details
- Founded
- Kyoto, JP Jan 1, 1897
- Last known activity
- May 1, 2025